Hologic clears regulatory hurdle in Canada for 2 HPV assays

04/8/2013 | GenomeWeb Daily News (free registration)

Hologic has obtained approval to market its Aptima HPV and Aptima HPV 16 18/45 tests in Canada. The genotype assays, which already have been approved by the FDA, work with the company's Tigris technology and are used to identify human papillomavirus strains that are linked to precancerous lesions and cervical cancer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI